Aethlon Medical, Inc. - AEMD

About Gravity Analytica
Recent News
- 02.12.2025 - Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update
- 02.12.2025 - Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update
- 02.05.2025 - Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025
- 02.05.2025 - Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025
- 02.05.2025 - Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025
- 02.05.2025 - Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025
- 01.29.2025 - Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial
- 01.29.2025 - Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial
- 01.29.2025 - Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial
- 01.29.2025 - Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial
Recent Filings
- 02.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
- 02.12.2025 - 8-K Current report
- 02.12.2025 - EX-99.1 EX-99.1
- 01.30.2025 - 1-A/A Offering Statement [Regulation A]
- 01.08.2025 - 8-K Current report
- 01.03.2025 - 4 Statement of changes in beneficial ownership of securities
- 01.03.2025 - 4 Statement of changes in beneficial ownership of securities
- 01.03.2025 - 4 Statement of changes in beneficial ownership of securities
- 12.27.2024 - 1-A Offering Statement [Regulation A]